Amniotic Membrane Market to reach $3.9 billion by 2035

Amniotic membrane market was valued at $1.5 billion in 2025 and is projected to reach $3.9 billion by 2035, growing at a CAGR of 10.2% during the forecast period (2026-2035). A key driver underpinning the growth of the amniotic membrane market is the increasing burden of chronic wounds, particularly those associated with diabetes, which continues to rise across major healthcare systems. According to the International Diabetes Federation, approximately 537 million adults were living Clinical evidence indicates that nearly 15% of individuals with diabetes are likely to develop diabetic foot ulcers during their lifetime, creating a sustained demand for effective wound management therapies. In addition, epidemiological data suggest that diabetic foot ulcers affect millions of patients annually, with approximately 18.6 million cases reported globally, indicates the scale of the clinical burden. These conditions are often characterized by delayed healing, high recurrence rates, and increased risk of complications, including infection and amputation. As a result, healthcare providers are increasingly adopting biologically active materials such as amniotic membranes that support faster tissue regeneration and reduce healing time. The transition from conventional wound care approaches to advanced biologics is becoming more evident, particularly in hospital and specialty care settings. This shift is directly influencing procurement patterns and treatment protocols, thereby strengthening market expansion.

Browse the full report description of “Amniotic Membrane Market Size, Share & Trends Analysis Report by Product Type (Cryopreserved Amniotic Membrane, Dehydrated Amniotic Membrane, and Lyophilized (Freeze-Dried) Amniotic Membrane), by Application (Ophthalmology, Wound Care, Orthopedics, Plastic & Reconstructive Surgery, and Others), by End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers (ASCs), and Research & Academic Institutes), Forecast Period (2026–2035)” at https://www.omrglobal.com/industry-reports/amniotic-membrane-market

The clinical and economic implications associated with chronic wounds further reinforce the importance of advanced regenerative therapies in healthcare systems. Studies indicate that diabetic foot ulcers require prolonged treatment durations, often extending over several months, which places a considerable burden on healthcare infrastructure and costs. In response, governments and healthcare institutions are increasingly emphasizing early intervention and the adoption of efficient treatment modalities to reduce long-term expenditure. Amniotic membrane products, known for their anti-inflammatory and healing properties, are being integrated into treatment pathways to improve patient outcomes and minimize complications. The growing geriatric population, which is more susceptible to chronic wounds, is also contributing to higher treatment demand. In parallel, increased screening initiatives and awareness programs are supporting early diagnosis and timely management of such conditions. Healthcare systems are gradually prioritizing solutions that combine clinical effectiveness with cost efficiency, positioning amniotic membrane-based therapies as a viable option. This alignment between clinical need and therapeutic capability continues to act as a strong foundation for market growth over the forecast period.

Innovation Leaders Transforming the Amniotic Membrane Market

The key players in the amniotic membrane market include Amnio Technology, LLC, Aziyo Biologics, Inc., Bio-Tissue, Inc. (Amniox Medical), MiMedx Group, Inc., Organogenesis Holdings Inc, among others. These companies are advancing innovation in amniotic membrane-based therapies through the development of biologically active allografts, enhanced preservation techniques, and multi-layer tissue engineering approaches, enabling improved wound healing, reduced inflammation, and effective tissue regeneration across ophthalmic, surgical, and chronic care applications while supporting the increasing clinical demand for reliable and minimally invasive regenerative treatment solutions.

• In December 2025, Organogenesis advanced its pipeline by initiating a biologics license application for ReNu, an amniotic membrane-based allograft targeting knee osteoarthritis management.
• In April 2024, West Point Optical Group, LLC and Verséa Ophthalmics, Inc. announced that the companies have entered into a partnership supply agreement in which Verséa Ophthalmics will be the exclusive provider of its BIOVANCE and BIOVANCE 3L Ocular products as the only human amniotic membrane tissue products used within WPOG practices to support the treatment of ocular surface disease and ocular surgical applications.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By Product Type
  • By Application
  • By End User
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape - Amnio Technology, LLC, Aziyo Biologics, Inc., Bio-Tissue, Inc. (Amniox Medical), MiMedx Group, Inc., Organogenesis Holdings Inc., among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Amniotic Membrane Market Report Segment

By Product Type

• Cryopreserved Amniotic Membrane
• Dehydrated Amniotic Membrane
• Lyophilized (Freeze-Dried) Amniotic Membrane

By Application

• Ophthalmology
• Wound Care
• Orthopedics
• Plastic & Reconstructive Surgery
• Others

By End User

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers (ASCs)
• Research & Academic Institutes

Global Amniotic Membrane Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/amniotic-membrane-market